During the past decade, The Emory Clinic at Chantilly conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "The Emory Clinic at Chantilly" are "Cystic Fibrosis" (2 trials). Many other conditions were trialed in "The Emory Clinic at Chantilly" in a lesser frequency.

Most popular intervention types in "The Emory Clinic at Chantilly" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "ELX/TEZ/IVA" (2 trials), "IVA" (2 trials), "Placebo (matched to ELX/TEZ/IVA)" (2 trials), "Placebo (matched to IVA)" (2 trials) and "Placebo (matched to VX-121/TEZ/D-IVA)" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Emory Clinic at Chantilly" are 2 trials for "All" genders.

Currently, there are NaN active trials in "The Emory Clinic at Chantilly". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in The Emory Clinic at Chantilly, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Emory Clinic at Chantilly, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".